全文获取类型
收费全文 | 32917篇 |
免费 | 2593篇 |
国内免费 | 134篇 |
专业分类
耳鼻咽喉 | 296篇 |
儿科学 | 772篇 |
妇产科学 | 485篇 |
基础医学 | 4772篇 |
口腔科学 | 586篇 |
临床医学 | 3666篇 |
内科学 | 7522篇 |
皮肤病学 | 758篇 |
神经病学 | 3243篇 |
特种医学 | 1452篇 |
外科学 | 5322篇 |
综合类 | 475篇 |
一般理论 | 17篇 |
预防医学 | 2180篇 |
眼科学 | 476篇 |
药学 | 1972篇 |
中国医学 | 17篇 |
肿瘤学 | 1633篇 |
出版年
2023年 | 204篇 |
2022年 | 271篇 |
2021年 | 623篇 |
2020年 | 409篇 |
2019年 | 581篇 |
2018年 | 612篇 |
2017年 | 499篇 |
2016年 | 636篇 |
2015年 | 651篇 |
2014年 | 928篇 |
2013年 | 1291篇 |
2012年 | 2058篇 |
2011年 | 1989篇 |
2010年 | 1164篇 |
2009年 | 1131篇 |
2008年 | 1806篇 |
2007年 | 1855篇 |
2006年 | 1800篇 |
2005年 | 1796篇 |
2004年 | 1633篇 |
2003年 | 1502篇 |
2002年 | 1372篇 |
2001年 | 713篇 |
2000年 | 780篇 |
1999年 | 671篇 |
1998年 | 380篇 |
1997年 | 335篇 |
1996年 | 273篇 |
1995年 | 237篇 |
1994年 | 213篇 |
1993年 | 211篇 |
1992年 | 535篇 |
1991年 | 502篇 |
1990年 | 452篇 |
1989年 | 434篇 |
1988年 | 414篇 |
1987年 | 394篇 |
1986年 | 382篇 |
1985年 | 344篇 |
1984年 | 344篇 |
1983年 | 245篇 |
1982年 | 163篇 |
1981年 | 156篇 |
1979年 | 276篇 |
1978年 | 175篇 |
1977年 | 148篇 |
1976年 | 146篇 |
1974年 | 186篇 |
1973年 | 178篇 |
1972年 | 171篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
2.
3.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
4.
Turnbull Chris D. Stockley James A. Madathil Shyam Huq Syed S. A. Cooper Brendan G. Ali Asad Wharton Simon Stradling John R. Heitmar Rebekka 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(7):2129-2139
Graefe's Archive for Clinical and Experimental Ophthalmology - Retinal microvascular endothelial dysfunction is thought to be of importance in the development of ocular vascular diseases.... 相似文献
5.
Stephan Koter Tina U. Cohnert Korbinian B. Hindermayr Jörg Lindenmann Maximilian Brückner Wolfgang K. Oswald Georg Werkgartner Doris Wagner 《Journal of vascular surgery》2019,69(4):1227-1232
Objective
Low psoas muscle area is shown to be an indicator for worse postoperative outcome in patients undergoing vascular surgical. Additionally, it has been associated with longer durations of hospital stay in patients with cancer who undergo surgery and subsequently greater health care costs in Europe and the United States. We sought to evaluate this effect on hospital expenditure for patients undergoing vascular repair in a health care system with universal access.Methods
Skeletal muscle mass was assessed on preoperative abdominal computed tomography scans of patients undergoing open aortic aneurysm repair in a retrospective fashion. The skeletal muscle index (SMI) was used to define low muscle mass. Health care costs were obtained for all patients and the relationship between a low SMI and higher costs was explored using linear regression and cross-sectional analysis.Results
We included 156 patients (81.5% male) with a median age of 72 years undergoing elective surgery for infrarenal abdominal aortic aneurysm in this analysis. The median SMI for patients with low skeletal muscle mass was 53.21 cm2/kg and for patients without, 70.07 cm2/kg. Hospital duration of stay was 2 days longer in patients with low skeletal muscle mass as compared with patients with normal (14 days vs 11 days; P = .001), as was duration of intensive care stay (3 days vs 1 day; P = .01). The median overall hospital costs were €10,460 higher for patients with a low SMI as compared with patients with a normal physical constitution (€53,739 [interquartile range, €45,007-€62,471] vs €43,279 [interquartile range, €39,509-€47,049]; P = .001). After confounder adjustment, a low SMI was associated with a 14.68% cost increase in overall hospital costs, for a cost increase of €6521.Conclusions
Low skeletal muscle mass is independently associated with higher hospital as well as intensive care costs in patients undergoing elective aortic aneurysm repair. Strategies to reduce this risk factor are warranted for these patients. 相似文献6.
7.
Stephan Kloos 《Medical anthropology》2020,39(2):167-181
ABSTRACTIn this article I explore, for the first time, the relationship between Sowa Rigpa (Tibetan medicine) and global health, tracing “the global” in ethical discourses and pharmaceutical innovation practices of Tibetan medical practitioners. I argue that Sowa Rigpa’s engagement with the world and its global health activities outside China can be understood as a form of “humanitarianism from below,” while its industrialization in China aligns with global health in different ways. In providing new insights into recent developments of Sowa Rigpa, I aim to decenter the notion of humanitarianism and contribute to a broader understanding of global health. 相似文献
8.
9.
best practice onkologie - 相似文献
10.